°øÁö»çÇ×

HOME > ÇÐȸ¼Ò°³   >   °øÁö»çÇ×

Çѱ¹´Ù¹ß¼º°ñ¼öÁ¾¿¬±¸È¸ Çà»ç ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
ÀÛ¼ºÀÏ
2006-04-06
Á¶È¸
8942
´ëÇÑÇ÷¾×ÇÐȸ »êÇÏ Çѱ¹´Ù¹ß¼º°ñ¼öÁ¾¿¬±¸È¸°¡ 4¿ù 8ÀÏ(Åä)¿¡ ÁغñÇÑ µÎ °¡Áö Çà»ç¸¦ Ç÷¾×ÇÐȸ ȸ¿ø´Ôµé²² °íÁöÇÏ¿À´Ï ¸¹Àº °ü½É°ú Âü¿©¸¦ ºÎŹµå¸³´Ï´Ù.

Çà»ç 1. : International Myeloma Foundation(IMF) Patient and Family Seoul Seminar
¼º °Ý : IMF°¡ ¾Æ½Ã¾Æ¿¡¼­´Â óÀ½ °³ÃÖÇϴ ȯÀÚ ¹× °¡Á· ¼¼¹Ì³ªÀÔ´Ï´Ù.
ÀÏ ½Ã : 2006³â 4¿ù 8ÀÏ(Åä) ¿ÀÈÄ 1:00 - 5:15
Àå ¼Ò : COEX º»°ü 4Ãþ ±×·£µå ÄÁÆÛ·±½º·ë
´ë »ó : ´Ù¹ß¼º°ñ¼öÁ¾À¸·Î Ä¡·á ÁßÀΠȯÀÚ¿Í °¡Á·
ÁÖ ÃÖ : ´ëÇÑÇ÷¾×ÇÐȸ, Çѱ¹Ç÷¾×¾ÏÇùȸ, ±¹Á¦°ñ¼öÁ¾Àç´Ü (IMF)
ÈÄ ¿ø : Çѱ¹³ë¹ÙƼ½º(ÁÖ)

»çÀüµî·ÏÀÌ ÇÊ¿äÇÕ´Ï´Ù : Çѱ¹Ç÷¾×¾ÏÇùȸ 02-3432-0807 (¼±Âø¼ø 650 ¸í ÀÔ´Ï´Ù)

ÇÁ·Î±×·¥

13:00¡­13:05 °³È¸»ç (¹Ú¼±¾ç / ´ëÇÑÇ÷¾×ÇÐȸ ÀÌ»çÀå)
13:05¡­13:10 °Ý·Á»ç (°íÈï±æ / Çѱ¹Ç÷¾×¾ÏÇùȸ ȸÀå)
13:10¡­13:20 ±¹Á¦°ñ¼öÁ¾Àç´Ü(IMF) ¼Ò°³ (S Novis / IMF ȸÀå)
13:20¡­13:40 ´Ù¹ß¼º °ñ¼öÁ¾ÀÇ ¼Ò°³ ¹× ¿ì¸®³ª¶óÀÇ ÇöȲ (ÀÌÀçÈÆ / °¡ÃµÀÇ´ë±æº´¿ø)
13:40¡­14:10 Áø´Ü, º´±â, ÁöÁö¿ä¹ý, °ú°Å¿Í ÇöÀç (Brian G.M Durie. MD)
(National Director for Hematologic Malignancies, Aptium Oncology, Inc.,
Chairman, International Myeloma Foundation)
14:10¡­14:30 Ç×¾ÏÈ­Çпä¹ý (±è¿©°æ / Àü³²È­¼øº´¿ø)
14:30¡­14:50 °í¿ë·®È­Çпä¹ý ¹× Á¶Ç÷¸ð¼¼Æ÷ÀÌ½Ä (À±¼º¼ö / ¼­¿ï´ëº´¿ø)
14:50¡­15:10 Áß°£ ÈÞ½Ä
15:10¡­15:40 ´Ù¹ß¼º°ñ¼öÁ¾ »À ÁúȯÀÇ Ä¡·á (Gregory R. Mundy, M.D)
(Professor of Cellular & Structural Biology, University of Texas Health Science Center)
15:40¡­16:00 ÇÁ·ÎÅ×¾ÆÁ» ¾ïÁ¦Á¦(º§ÄÉÀ̵å) (¼Õ»ó±Õ / °æºÏ´ëº´¿ø)
16:00¡­16:20 Å»¸®µµ¸¶À̵å¿Í À¯µµÃ¼ (±è±âÇö / »ï¼º¼­¿ïº´¿ø)
16:20¡­16:40 Àü¹ÝÀû Ä¡·á¹æħ (¼­Ã¶¿ø /¼­¿ï¾Æ»êº´¿ø)
16:40¡­17:10 ÁúÀÇÀÀ´ä
17:10¡­17:15 Æóȸ»ç (Á¶°æ»ï / ´ëÇÑÇ÷¾×ÇÐȸ ȸÀå)

¡Ø ¹®ÀÇ ¹× Á¢¼ö : Çѱ¹Ç÷¾×¾ÏÇùȸ »ç¹«Ã³ 02-3432-0807


Çà»ç 2 : 2006 Seoul Multiple Myeloma Symposium
ÀÏ ½Ã : 2006³â 4¿ù 8ÀÏ(Åä) ¿ÀÈÄ 6:00 - 9:00
Àå ¼Ò : ±×·£µåÀÎÅÍÄÁƼ³ÙÅ» È£ÅÚ 2Ãþ ±¹È­·ë
´ë »ó : ´Ù¹ß¼º°ñ¼öÁ¾À» ¿¬±¸/Ä¡·áÇÏ´Â ÀÇ»çµé
ÁÖ ÃÖ : ¢ß Çѱ¹ ³ë¹ÙƼ½º

ÇÁ·Î±×·¥

6:00¡­6:10 Welcome Address (Peter Maag : President, Novartis Korea)

Part 1. Multiple Myeloma in Korea (Chair : prof . Seonyang Park)

6:10-6:30 Epidemiology of Multiple Myeloma in Korea
(Jae Hoon Lee M.D., Dept of Internal Medicine, Gil Hospital)
6:30-6:50 Cytogenetic study in Korean patients with Multiple Myeloma
(Dong Soon Lee M.D., Dept of Laboratory Medicine, Seoul National University Hospital)

6:50-7:00 Coffee break

Part 2. Management of bone disease in Multiple Myeloma (Chair : prof. Kyung Sam Cho )

7:00-7:20 Role of Bisphosphonate in the management of myeloma bone disease
(Gregory R. Mundy, M.D., Professor of Cellular & Structural Biology, University of Texas Health Science Center)
7:20-7:40 Surgical management of myeloma bone disease. (Percutaneous Vertebroplasty)
(Jee Soo Chang M.D., Dept of Neurosurgery, Our Hospital)
7:40-8:00 The anti-tumor potential of Zoledronic Acid in Multiple Myeloma - Asia Pacific Dtz Trial Update.
(Gerrard Teoh M.D.,Clinician-Scientist, SingHealth, Consultant, Dept of Haematology, SGH )

Part 3. Dinner (8:00-9:00)